TABLE OF CONTENTS
1 INTRODUCTION 54
1.1 OBJECTIVES OF THE STUDY 54
1.2 MARKET DEFINITION 54
1.3 OVERVIEW OF THE NORTH AMERICA POLYETHYLENE GLYCOL MARKET 54
1.4 LIMITATIONS 56
1.5 MARKETS COVERED 56
2 MARKET SEGMENTATION 59
2.1 MARKETS COVERED 59
2.2 GEOGRAPHICAL SCOPE 60
2.3 YEARS CONSIDERED FOR THE STUDY 61
2.4 CURRENCY AND PRICING 61
2.5 DBMR TRIPOD DATA VALIDATION MODEL 62
2.6 MULTIVARIATE MODELLING 65
2.7 TREATMENT LIFELINE CURVE 65
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 66
2.9 DBMR MARKET POSITION GRID 67
2.10 MARKET APPLICATION COVERAGE GRID 68
2.11 SECONDARY SOURCES 69
2.12 ASSUMPTIONS 69
3 EXECUTIVE SUMMARY 70
4 PREMIUM INSIGHTS 73
4.1 PESTEL ANALYSIS 74
4.2 PORTER'S FIVE FORCES: 77
4.3 REGULATORY FRAMEWORK 79
4.4 IMPORT EXPORT SCENARIO 81
4.5 PRODUCTION CONSUMPTION ANALYSIS 89
4.6 RAW MATERIAL COVERAGE NORTH AMERICA POLYETHYLENE GLYCOL MARKET 90
4.7 TECHNOLOGICAL ADVANCEMENT BY MANUFACTURERS 91
4.8 VENDOR SELECTION CRITERIA 92
5 NORTH AMERICA POLYETHYLENE GLYCOL MARKET: PRICE INDEX 93
6 PRODUCTION CAPACITY 94
7 SUPPLY CHAIN ANALYSIS 95
7.1 OVERVIEW 95
7.2 LOGISTIC COST SCENARIO 95
7.3 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS 95
8 MARKET OVERVIEW 96
8.1 DRIVERS 98
8.1.1 GROWING DEMAND FOR MEDICINES 98
8.1.2 HIGH DEMAND OF ICE-CREAMS 98
8.1.3 USAGE OF PEGLYCATION TECHNOLOGY IN BIOTECHNOLOGICAL AND PHARMACEUTICAL APPLICATIONS 99
8.1.4 HIGH DEMAND FOR WATER-BASED PAINTS 100
8.2 RESTRAINTS 100
8.2.1 VISCOSITY STABILITY ISSUES IN PEG 100
8.2.2 STRICT REGULATIONS IN THE PHARMACEUTICAL INDUSTRY 101
8.2.3 ENVIRONMENTAL REGULATIONS 101
8.2.4 HIGH DEMAND FOR SUBSTITUTES 102
8.3 OPPORTUNITIES 102
8.3.1 PRODUCTION OF POLYETHYLENE GLYCOL- 400 FOR EYE DROP APPLICATIONS 102
8.3.2 PRODUCTION OF PEG FOR SKIN THERAPY AND OINTMENT APPLICATIONS 103
8.3.3 USE OF POLYETHYLENE GLYCOL AS AN ADDITIVES TO IMPROVE THE PROPERTIES OF PAINT AND COATINGS 103
8.4 CHALLENGES 104
8.4.1 FLUCTUATING RAW MATERIAL PRICES 104
8.4.2 HIGH IMPORT TARIFFS AND REGULATIONS 104
8.4.3 IMMEDIATE ALLERGIC REACTIONS OF PEG 105
9 NORTH AMERICA POLYETHYLENE GLYCOL MARKET, BY GRADE 106
9.1 OVERVIEW 107
9.2 PEG 400 109
9.3 PEG 600 110
9.4 PEG 200 111
9.5 PEG 300 112
9.6 PEG 1000 113
9.7 PEG 3350 114
9.8 PEG 4000 115
9.9 PEG 8000 116
9.10 PEG 6000 117
9.11 PEG 10000 118
9.12 PEG 20000 119
10 NORTH AMERICA POLYETHYLENE GLYCOL MARKET, BY FORM 120
10.1 OVERVIEW 121
10.2 OPAQUE LIQUID 122
10.3 FLAKES/POWDER 123
10.4 WHITE WAXY SOLID 124
11 NORTH AMERICA POLYETHYLENE GLYCOL MARKET, BY PACKAGING SIZE 126
11.1 OVERVIEW 127
11.2 DRUMS 128
11.3 PLASTIC BOTTLES 129
12 NORTH AMERICA POLYETHYLENE GLYCOL MARKET, BY APPLICATION 131
12.1 OVERVIEW 132
12.2 HEALTHCARE 133
12.2.1 PHARMACEUTICALS 135
12.2.1.1 TABLETS 136
12.2.1.2 OINTMENTS 136
12.2.2 COLONOSCOPY 136
12.2.3 BARIUM ENEMA PREPARATION 136
12.3 INDUSTRIAL 136
12.4 COSMETICS/PERSONAL CARE 137
12.4.1 SKIN CREAM 139
12.4.2 TOOTHPASTE 139
12.4.3 PERSONAL LUBRICANTS 139
12.4.4 OTHERS 139
12.5 BUILDING AND CONSTRUCTION 139
12.5.1 PAINTS AND COATINGS 141
12.5.2 CERAMIC TILES 141
12.5.3 OTHERS 141
12.6 OTHERS 141
13 NORTH AMERICA POLYETHYLENE GLYCOL MARKET, BY REGION 143
13.1 NORTH AMERICA 144
13.1.1 U.S. 155
13.1.2 CANADA 161
13.1.3 MEXICO 167
14 COMPANY LANDSCAPE 173
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 173
15 SWOT ANALYSIS 174
16 COMPANY PROFILE 175
16.1 SABIC 175
16.1.1 COMPANY SNAPSHOT 175
16.1.2 REVENUE ANALYSIS 175
16.1.3 COMPANY SHARE ANALYSIS 176
16.1.4 PRODUCT PORTFOLIO 176
16.1.5 RECENT DEVELOPMENTS 177
16.2 MERCK KGAA 178
16.2.1 COMPANY SNAPSHOT 178
16.2.2 REVENUE ANALYSIS 178
16.2.3 COMPANY SHARE ANALYSIS 179
16.2.4 PRODUCT PORTFOLIO 179
16.2.5 RECENT DEVELOPMENTS 180
16.3 DOW 181
16.3.1 COMPANY SNAPSHOT 181
16.3.2 REVENUE ANALYSIS 181
16.3.3 COMPANY SHARE ANALYSIS 182
16.3.4 PRODUCT PORTFOLIO 182
16.3.5 RECENT DEVELOPMENTS 183
16.4 BASF SE 184
16.4.1 COMPANY SNAPSHOT 184
16.4.2 REVENUE ANALYSIS 184
16.4.3 COMPANY SHARE ANALYSIS 185
16.4.4 PRODUCT PORTFOLIO 185
16.4.5 RECENT DEVELOPMENTS 186
16.5 INEOS 187
16.5.1 COMPANY SNAPSHOT 187
16.5.2 REVENUE ANALYSIS 187
16.5.3 COMPANY SHARE ANALYSIS 188
16.5.4 PRODUCT PORTFOLIO 188
16.5.5 RECENT DEVELOPMENTS 189
16.6 LOTTE CHEMICAL CORPORATION 190
16.6.1 COMPANY SNAPSHOT 190
16.6.2 REVENUE ANALYSIS 190
16.6.3 COMPANY SHARE ANALYSIS 191
16.6.4 PRODUCT PORTFOLIO 191
16.6.5 RECENT DEVELOPMENTS 191
16.7 HEFEI TNJ CHEMICAL INDUSTRY CO., LTD. 192
16.7.1 COMPANY SNAPSHOT 192
16.7.2 PRODUCT PORTFOLIO 192
16.7.3 RECENT DEVELOPMENTS 193
16.8 CLARIANT 194
16.8.1 COMPANY SNAPSHOT 194
16.8.2 REVENUE ANALYSIS 194
16.8.3 PRODUCT PORTFOLIO 195
16.8.4 RECENT DEVELOPMENT 195
16.9 CRODA INTERNATIONAL PLC 196
16.9.1 COMPANY SNAPSHOT 196
16.9.2 REVENUE ANALYSIS 196
16.9.3 PRODUCT PORTFOLIO 197
16.9.4 RECENT DEVELOPMENTS 197
16.10 GFS CHEMICALS, INC. 199
16.10.1 COMPANY SNAPSHOT 199
16.10.2 PRODUCT PORTFOLIO 199
16.10.3 RECENT DEVELOPMENT 200
16.11 INDIA GLYCOLS LIMITED 201
16.11.1 COMPANY SNAPSHOT 201
16.11.2 REVENUE ANALYSIS 201
16.11.3 PRODUCT PORTFOLIO 202
16.11.4 RECENT DEVELOPMENTS 202
16.12 LIAONING KELONG FINE CHEMICAL CO., LTD. 203
16.12.1 COMPANY SNAPSHOT 203
16.12.2 PRODUCT PORTFOLIO 203
16.12.3 RECENT DEVELOPMENTS 203
16.13 LIAONING OXIRANCHEM INC. 204
16.13.1 COMPANY SNAPSHOT 204
16.13.2 PRODUCT PORTFOLIO 204
16.13.3 RECENT DEVELOPMENTS 204
16.14 MIL-SPEC INDUSTRIES CORPORATION 205
16.14.1 COMPANY SNAPSHOT 205
16.14.2 PRODUCT PORTFOLIO 205
16.14.3 RECENT DEVELOPMENT 205
16.15 NOAH CHEMICALS 206
16.15.1 COMPANY SNAPSHOT 206
16.15.2 PRODUCT PORTFOLIO 206
16.15.3 RECENT DEVELOPMENT 206
16.16 PROCHEM, INC 207
16.16.1 COMPANY SNAPSHOT 207
16.16.2 PRODUCT PORTFOLIO 207
16.16.3 RECENT DEVELOPMENT 207
17 QUESTIONNAIRE 208
18 RELATED REPORTS 211

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.